Secondary Patents
Johnson & Johnson’s TB drug deal will fail to reach all those in need
A recent deal struck between Johnson & Johnson and the Global Drug Facility promises improved access to bedaquiline in a number of low income countries, but fails to address structural problems
- Trump’s mass deportation operation escalates with workplace raids
- Jordan bans Muslim Brotherhood, confiscates its assets after alleged security plot
- Medics on hunger strike against Gaza genocide reach European Parliament
- Samidoun Europe coordinator targeted again by Belgian police
- Syria’s interim government arrests senior Palestinian resistance leaders
